217 filings
Page 5 of 11
F-3/A
6ag78 pc7xwrxul
7 Sep 21
Shelf registration (foreign) (amended)
4:06pm
CORRESP
2i493lg3
7 Sep 21
Correspondence with SEC
12:00am
UPLOAD
ppdgvc
20 Aug 21
Letter from SEC
12:00am
F-6EF
rrvky4qd rw00qopts61
13 Aug 21
Automatic registration for ADRs (foreign)
5:24pm
F-3
a8waumj3zrz fjr1i
5 Aug 21
Shelf registration (foreign)
4:33pm
6-K
txsiar
20 Jul 21
Current report (foreign)
4:16pm
6-K
46z66sifrmhlrbnm4tg
2 Jun 21
Current report (foreign)
8:24am
6-K
uooqoaz67m0k90rhl
28 May 21
Current report (foreign)
4:07pm
6-K
sr61kx0ysb8co96
30 Apr 21
Mereo BioPharma and Cancer Focus Fund Announce Partnership for Phase 1b/2 Study of Etigilimab in Clear Cell Ovarian Cancer
4:05pm
6-K
w44 cdwha94thrg95uma
16 Apr 21
Current report (foreign)
4:10pm
6-K
0oruubz
31 Mar 21
Mereo BioPharma Reports Full Year 2020 Financial Results and Recent Highlights
5:13pm
6-K
tn8103ky27
12 Feb 21
Current report (foreign)
4:06pm
6-K
gickub eidwebv2
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
424B5
epx9hf 6fck8qil1b
10 Feb 21
Prospectus supplement for primary offering
4:53pm
424B5
gxibcz
9 Feb 21
Prospectus supplement for primary offering
5:24pm
6-K
jc6 p87wvm
1 Feb 21
Current report (foreign)
5:06pm
S-8
fdhbdocn6
15 Jan 21
Registration of securities for employees
4:21pm
6-K
dedsyvsln9uyjitg
14 Jan 21
Current report (foreign)
7:06am
6-K
psmyn864kdl y4e2
17 Dec 20
Mereo BioPharma and Ultragenyx Announce Collaboration and License
5:16pm